US Stock MarketDetailed Quotes

Grace Therapeutics (GRCE)

Watchlist
  • 2.160
  • -0.030-1.37%
Close May 15 15:59 ET
  • 2.157
  • -0.004-0.16%
Post 20:01 ET
33.42MMarket Cap-6.97P/E (TTM)

Grace Therapeutics (GRCE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-33.88%2.45M
-47.65%2.53M
-37.74%3.09M
46.73%16.68M
-2.45%3.18M
21.72%3.7M
130.93%4.83M
67.16%4.96M
-37.70%11.37M
-21.66%3.26M
Selling and administrative expenses
31.54%1.99M
5.77%1.96M
-5.37%2.13M
7.78%7.16M
0.26%1.55M
-5.69%1.51M
13.61%1.85M
20.47%2.25M
-19.09%6.64M
-38.67%1.54M
-Selling and marketing expense
----
----
----
----
----
----
----
----
42.65%194K
----
-General and administrative expense
31.54%1.99M
5.77%1.96M
-5.37%2.13M
7.78%7.16M
0.26%1.55M
-5.69%1.51M
13.61%1.85M
20.47%2.25M
-17.73%6.64M
-37.40%1.54M
Research and development costs
-78.94%462K
-80.91%568K
-64.73%955K
103.10%9.51M
-3.03%1.63M
52.04%2.19M
546.96%2.98M
147.31%2.71M
-53.04%4.68M
2.74%1.69M
Depreciation amortization depletion
100.00%2K
-50.00%1K
100.00%2K
-82.50%7K
-94.29%2K
--1K
100.00%2K
-66.67%1K
-36.51%40K
288.89%35K
-Depreciation and amortization
100.00%2K
-50.00%1K
100.00%2K
-82.50%7K
-94.29%2K
--1K
100.00%2K
-66.67%1K
-36.51%40K
288.89%35K
Operating profit
33.88%-2.45M
47.65%-2.53M
37.74%-3.09M
-46.73%-16.68M
2.45%-3.18M
-21.72%-3.7M
-130.93%-4.83M
-67.16%-4.96M
37.70%-11.37M
21.66%-3.26M
Net non-operating interest income expense
23.19%170K
0.00%172K
-12.77%205K
-21.95%711K
-32.93%167K
-56.33%138K
-18.87%172K
75.37%235K
270.33%911K
122.32%249K
Non-operating interest income
23.19%170K
0.00%172K
-12.77%205K
-21.95%711K
-32.93%167K
-56.33%138K
-18.87%172K
75.37%235K
270.33%911K
122.32%249K
Other net income (expense)
96.98%-36K
278.40%1.42M
-134.39%-477K
175.69%3.2M
353.03%2.63M
-1,032.81%-1.19M
120.39%375K
193.91%1.39M
87.55%-4.23M
96.93%-1.04M
Gain on sale of security
96.98%-36K
278.40%1.42M
-134.39%-477K
216.65%3.2M
353.03%2.63M
-1,032.81%-1.19M
120.39%375K
17,237.50%1.39M
-4,325.81%-2.74M
-34,800.00%-1.04M
Special income (charges)
----
----
----
--0
--0
--0
--0
--0
95.62%-1.49M
--0
-Less:Restructuring and merger&acquisition
----
----
----
--0
--0
--0
--0
--0
--1.49M
--0
-Less:Impairment of capital assets
----
----
----
----
----
----
----
----
--0
----
-Write off
----
----
----
----
----
----
----
----
--0
----
Income before tax
51.37%-2.32M
78.10%-938K
-0.63%-3.36M
13.06%-12.77M
90.58%-382K
-83.15%-4.76M
-15.19%-4.28M
22.52%-3.34M
71.74%-14.69M
89.32%-4.06M
Income tax
0
0
0
-74.62%-3.2M
-14.51%-1.02M
-190.87%-605K
-91.03%-852K
-150.52%-724K
80.80%-1.83M
89.98%-889K
Net income
44.28%-2.32M
72.67%-938K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
Net income continuous Operations
44.28%-2.32M
72.67%-938K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
Minority interest income
Net income attributable to the parent company
44.28%-2.32M
72.67%-938K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
44.28%-2.32M
72.67%-938K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
Basic earnings per share
61.11%-0.14
80.00%-0.06
12.50%-0.21
41.48%-0.79
138.46%0.1
-71.43%-0.36
30.23%-0.3
55.56%-0.24
76.36%-1.35
93.35%-0.26
Diluted earnings per share
61.11%-0.14
80.00%-0.06
12.50%-0.21
41.48%-0.79
138.46%0.1
-71.43%-0.36
30.23%-0.3
55.56%-0.24
76.36%-1.35
93.35%-0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -33.88%2.45M-47.65%2.53M-37.74%3.09M46.73%16.68M-2.45%3.18M21.72%3.7M130.93%4.83M67.16%4.96M-37.70%11.37M-21.66%3.26M
Selling and administrative expenses 31.54%1.99M5.77%1.96M-5.37%2.13M7.78%7.16M0.26%1.55M-5.69%1.51M13.61%1.85M20.47%2.25M-19.09%6.64M-38.67%1.54M
-Selling and marketing expense --------------------------------42.65%194K----
-General and administrative expense 31.54%1.99M5.77%1.96M-5.37%2.13M7.78%7.16M0.26%1.55M-5.69%1.51M13.61%1.85M20.47%2.25M-17.73%6.64M-37.40%1.54M
Research and development costs -78.94%462K-80.91%568K-64.73%955K103.10%9.51M-3.03%1.63M52.04%2.19M546.96%2.98M147.31%2.71M-53.04%4.68M2.74%1.69M
Depreciation amortization depletion 100.00%2K-50.00%1K100.00%2K-82.50%7K-94.29%2K--1K100.00%2K-66.67%1K-36.51%40K288.89%35K
-Depreciation and amortization 100.00%2K-50.00%1K100.00%2K-82.50%7K-94.29%2K--1K100.00%2K-66.67%1K-36.51%40K288.89%35K
Operating profit 33.88%-2.45M47.65%-2.53M37.74%-3.09M-46.73%-16.68M2.45%-3.18M-21.72%-3.7M-130.93%-4.83M-67.16%-4.96M37.70%-11.37M21.66%-3.26M
Net non-operating interest income expense 23.19%170K0.00%172K-12.77%205K-21.95%711K-32.93%167K-56.33%138K-18.87%172K75.37%235K270.33%911K122.32%249K
Non-operating interest income 23.19%170K0.00%172K-12.77%205K-21.95%711K-32.93%167K-56.33%138K-18.87%172K75.37%235K270.33%911K122.32%249K
Other net income (expense) 96.98%-36K278.40%1.42M-134.39%-477K175.69%3.2M353.03%2.63M-1,032.81%-1.19M120.39%375K193.91%1.39M87.55%-4.23M96.93%-1.04M
Gain on sale of security 96.98%-36K278.40%1.42M-134.39%-477K216.65%3.2M353.03%2.63M-1,032.81%-1.19M120.39%375K17,237.50%1.39M-4,325.81%-2.74M-34,800.00%-1.04M
Special income (charges) --------------0--0--0--0--095.62%-1.49M--0
-Less:Restructuring and merger&acquisition --------------0--0--0--0--0--1.49M--0
-Less:Impairment of capital assets ----------------------------------0----
-Write off ----------------------------------0----
Income before tax 51.37%-2.32M78.10%-938K-0.63%-3.36M13.06%-12.77M90.58%-382K-83.15%-4.76M-15.19%-4.28M22.52%-3.34M71.74%-14.69M89.32%-4.06M
Income tax 000-74.62%-3.2M-14.51%-1.02M-190.87%-605K-91.03%-852K-150.52%-724K80.80%-1.83M89.98%-889K
Net income 44.28%-2.32M72.67%-938K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M
Net income continuous Operations 44.28%-2.32M72.67%-938K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M
Minority interest income
Net income attributable to the parent company 44.28%-2.32M72.67%-938K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 44.28%-2.32M72.67%-938K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M
Basic earnings per share 61.11%-0.1480.00%-0.0612.50%-0.2141.48%-0.79138.46%0.1-71.43%-0.3630.23%-0.355.56%-0.2476.36%-1.3593.35%-0.26
Diluted earnings per share 61.11%-0.1480.00%-0.0612.50%-0.2141.48%-0.79138.46%0.1-71.43%-0.3630.23%-0.355.56%-0.2476.36%-1.3593.35%-0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More